Abstract:Background: In brain lysates denatured huntingtin is full-length and fragmented. Results: Blue Native PAGE analysis revealed huntingtin as a soluble full-length monomer and resistant to exogenous protease cleavage. Exposure to denaturants cleaved mutant huntingtin. Conclusion: Native mutant huntingtin in brain is unstable compared with wild-type huntingtin. Significance: Native conditions may improve detection of full-length huntingtin in human brain. Huntington disease (HD) is caused by polyglutamine expansion in the N terminus of huntingtin (htt). Analysis of human postmortem brain lysates by SDS-PAGE and Western blot reveals htt as full-length and fragmented. Here we used Blue Native PAGE (BNP) and Western blots to study native htt in human postmortem brain. Antisera against htt detected a single band broadly migrating at 575–850 kDa in control brain and at 650–885 kDa in heterozygous and Venezuelan homozygous HD brains. Anti-polyglutamine antisera detected full-length mutant htt in HD brain. There was little htt cleavage even if lysates were pretreated with trypsin, indicating a property of native htt to resist protease cleavage. A soluble mutant htt fragment of about 180 kDa was detected with anti-htt antibody Ab1 (htt-(1–17)) and increased when lysates were treated with denaturants (SDS, 8 m urea, DTT, or trypsin) before BNP. Wild-type htt was more resistant to denaturants. Based on migration of in vitro translated htt fragments, the 180-kDa segment terminated ≈htt 670–880 amino acids. If second dimension SDS-PAGE followed BNP, the 180-kDa mutant htt was absent, and 43–50 kDa htt fragments appeared. Brain lysates from two HD mouse models expressed native full-length htt; a mutant fragment formed if lysates were pretreated with 8 m urea + DTT. Native full-length mutant htt in embryonic HD140Q/140Q mouse primary neurons was intact during cell death and when cell lysates were exposed to denaturants before BNP. Thus, native mutant htt occurs in brain and primary neurons as a soluble full-length monomer.

Caspase 3-Cleaved N-terminal Fragments of Wild-Type and Mutant Huntingtin Are Present in Normal and Huntington's Disease Brains, Associate with Membranes, and Undergo Calpain-Dependent Proteolysis.

Lysosomal proteases are involved in generation of N-terminal huntingtin fragments.

Soluble N-terminal Fragment of Mutant Huntingtin Protein Impairs Mitochondrial Axonal Transport in Cultured Hippocampal Neurons.

Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates

Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease

Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

Autophagy regulates the processing of amino terminal huntingtin fragments.

Native Mutant Huntingtin in Human Brain

Intranuclear Huntingtin Increases the Expression of Caspase-1 and Induces Apoptosis

Huntingtin Forms Toxic Nh2-Terminal Fragment Complexes That Are Promoted By The Age-Dependent Decrease In Proteasome Activity

Truncated N-terminal Huntingtin Fragment with Expanded-Polyglutamine (Htt552-100Q) Suppresses Brain-Derived Neurotrophic Factor Transcription in Astrocytes.

N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking

The role of caspase and calpain in neuronal apoptosis and pathogenesis of Huntington disease

Accumulation of N-terminal Mutant Huntingtin in Mouse and Monkey Models Implicated As a Pathogenic Mechanism in Huntington's Disease

Caspase Activation During Apoptotic Cell Death Induced by Expanded Polyglutamine in N2a Cells.

Huntingtin Aggregates May Not Predict Neuronal Death in Huntington's Disease

Ubiquitin-Activating Enzyme Activity Contributes to Differential Accumulation of Mutant Huntingtin in Brain and Peripheral Tissues

A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients

Mutant Huntingtin and Glycogen Synthase Kinase 3‐β Accumulate in Neuronal Lipid Rafts of a Presymptomatic Knock‐in Mouse Model of Huntington's Disease

Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.